• 1
    Ralston S, de Crombrugghe B 2006 Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 20: 24922506.
  • 2
    Williams F, Spector T 2006 Recent advances in the genetics of osteoporosis. J Musculoskelet Neuronal Interact 6: 2735.
  • 3
    Huang QY, Recker RR, Deng HW 2003 Searching for osteoporosis genes in the post-genome era: Progress and challenges. Osteoporos Int 14: 701715.
  • 4
    Beamer WG, Shultz KL, Donahue LR, Churchill G, Sen S, Wergedal JR, Baylink DJ, Rosen CJ 2001 Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. J Bone Miner Res 16: 11951206.
  • 5
    Rosen CJ, Churchill G, Donahue LR, Shultz K, Burgess JK, Powell DR, Ackert C, Beamer WG 2000 Mapping quantitative trait loci for serum insulin-like growth factor-I levels in mice. Bone 27: 521528.
  • 6
    Bouxsein ML, Rosen CJ, Turner CH, Ackert C, Shultz K, Donahue LR, Churchill G, Adamo ML, Powell DR, Turner RT, Muller R, Beamer WG 2002 Generation of a new congenic mouse strain to test the relationship among serum insulin-like growth factor I, bone mineral density and skeletal morphology in vivo. J Bone Miner Res 17: 570579.
  • 7
    Rosen CJ, Ackert-Bicknell C, Adamo ML, Shultz K, Rubin J, Donahue LR, Horton L, Delahunty KM, Beamer WG, Sipos J, Clemmons D, Nelson T, Bouxsein ML, Horowitz M 2004 Congenic mice with low serum IGF-1 have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Bone 35: 10461058.
  • 8
    Deng HW, Xu FH, Huang QY, Shen H, Deng H, Conway T, Liu YJ, Lui YZ, Li JL, Zhang HT, Davies KM, Recker RR 2002 A whole-genome linkage scan suggests several genomic regions potentially containing quantitative trait loci for osteoporosis. J Clin Endocrinol Metab 87: 51515159.
  • 9
    Lee YH, Rho YH, Choi SJ, Ji JD, Song GG 2006 Meta-analysis of genome-wide linkage studies for bone mineral density. J Hum Genet 51: 480486.
  • 10
    Ioannidis J, Ng M, Sham P, Zintzaras E, Lewis C, Deng H, Econs M, Karasik D, Devoto M, Kammerer C, Spector T, Andrew T, Cupples L, Foroud T, Kiel D, Koller D, Langdahl B, Mitchell B, Peacock M, Recker R, Shen H, Sol-Church K, Spotila L, Uitterlinden A, Wilson S, Kung A, Ralston S 2007 Meta-analysis of genome wide scans provides evidence for gender and site specific regulation of bone mass. J Bone Miner Res 22: 173183.
  • 11
    Corwin R, Hartmen T, Maczuga S, Graubard B 2006 Dietary saturated fat is inversely associated with bone density in humans: Analysis of NHANES III. J Nutr 136: 159165.
  • 12
    Brownbill R, Ilich J 2006 Lipid profile and bone paradox: Higher serum lipids are asociated with higher bone mineral density in postmenopausal women. J Womens Health 15: 261270.
  • 13
    Kruger M, Coetzer H, de Winter R, Gericke G, van Papendorp D 1998 Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging Clin Exp Res 10: 385394.
  • 14
    Bassey E, Littlewood J, Rothwell M, Pye D 2000 Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: Two randomized control trials of Efacal v. calcium alone. Br J Nutr 83: 629635.
  • 15
    Svenson K, Bogue M, Peters L 2003 Identifying new mouse models of cardiovascular disease: A review of high-throughput screens of mutagenized and inbred strains. J Appl Physiol 94: 16501659.
  • 16
    Ackert-Bicknell C, Salisbury J, Horowitz M, Demambro V, Horton L, Shultz KL, Lecka-Czernik B, Rosen CJ 2008 A chromosomal inversion within a Quantitative Trait Locus has a major effect on adipogenesis and osteoblastogenesis. Ann NY Acad Sci 1116: 291305.
  • 17
    Park Y, Clifford R, Buetow K, Hunter K 2003 Multiple cross and inbred strain haplotype mapping of complex-trait candidate genes. Genome Res 13: 118121.
  • 18
    Delahunty KM, Shultz KL, Gronowicz G, Koczon-Jaremko B, Adamo ML, Horton L, Lorenzon J, Donahue LR, Ackert-Bicknell C, Kream B, Beamer WG, Rosen CJ 2006 Congenic mice provide in vivo evidence fr a genetic locus that modulates serum IGF-1 and bone acquisition. Endocrinology 147: 39153923.
  • 19
    Ferrari S, Karasik D, Liu J, Karamohamed S, Herbert A, Cupples LA, Kiel DP 2004 Interactions of interleukin-6 promoter polymorphisms with dietary factors and their associations with bone mass in men and in women from the Framingham Osteoporosis Study. J Bone Miner Res 19: 552559.
  • 20
    Karasik D, Myers R, Cupples LA, Hannan MT, Gagnon DR, Herbert A, Kiel DP 2002 Genome screen for quantitative trait loci contributing to normal variation in bone mineral density: The Framingham Study. J Bone Miner Res 17: 17181727.
  • 21
    Hannan MT, Tucker KL, Dawson-Hughes B, Cupples LA, Felson D, Kiel DP 2000 Effect of dietary protein on bone loss in elderly men and women: The Framingham Osteoporosis Study. J Bone Miner Res 15: 25042512.
  • 22
    London S, Sacks F, Caesar J, Stampfer M, Siguel E, Willett W 1991 Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. Am J Clin Nutr 54: 340345.
  • 23
    Garland M, Sacks F, Colditz G, Rimm E, Sampson L, Willett W, Hunter D 1998 The relationship between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr 67: 2530.
  • 24
    Hunter D, Rimm E, Sacks F, Stampfer M, Colditz G, Litin L, Willett W 1992 Comparison measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol 135: 418427.
  • 25
    Willett W, Stampfer M, Chu N, Spiegelman D, Holmes M, Rimm E 2001 Assessment of questionnaire validity for measuring total fat intake using plasma lipid levels as criteria. Am J Epidemiol 154: 11071112.
  • 26
    Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, Deeb S, Auwerx J, Amouyel P 1998 A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet 7: 435440.
  • 27
    Knouff C, Auwerx J 2004 Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: Lessons from genetics and pharmacology. Endocr Rev 25: 899918.
  • 28
    Stram D, Haiman C, Hirschhorn J, Altshuler D, Kolonel L, Henderson B, Pike M 2003 Choosing haplotype-tagging SNPS based on unphased genotype data using preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered 51: 2736.
  • 29
    Abdelmagid S, Barbe M, Arango-Hisijara I, Owen T, Popoff S, Safadi F 2007 Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function. J Cell Physiol 210: 2637.
  • 30
    Davidson R, Waters J, Kevorkian L, Darrah C, Cooper A, Donell S, Clark I 2006 Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther 8: R124.
  • 31
    Kaneko Y, Tanzawa H, Sato K 1994 The proto-oncogene C-raf-1 is highly expressed only in the hypertrophic zone of the growth plate. Calcif Tissue Int 54: 426430.
  • 32
    Gao Y, Kobayashi H, Ganss B 2003 The human KROX-26/ZNF22 gene is expressed at sites of tooth formation and maps to the locus for permanent tooth agenesis (He-Zhao deficiency). J Dent Res 82: 10021007.
  • 33
    Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung U-I, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H 2004 PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113: 846855.
  • 34
    Inoue M, Ohtake T, Motomura W, Takahashi N, Hosoki Y, Miyoshi S, Suzuki Y, Saito H, Kohgo Y, Okumura T 2005 Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice. Biochem Biophys Res Commun 336: 215222.
  • 35
    Yu S, Matsusue K, Kashireddy P, Cao W-Q, Yeldandi V, Yeldandi A, Rao M, Gonzalez FJ, Reddy JK 2003 Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to Peroxisome Proliferator-activated Receptor gamma1 (PPARgamma1) overexpression. J Biol Chem 278: 498505.
  • 36
    Spiegelman BM 1998 PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor. Diabetes 47: 507514.
  • 37
    Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM 1999 PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4: 585595.
  • 38
    Rosen E, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Speigelman BM, Mortensen RM 1999 PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4: 611617.
  • 39
    Lecka-Czernik B, Suva L 2008 Resolving the two “bony” faces of PPAR-gamma. PPAR Res 2006: 27489.
  • 40
    Afshan A, Weinstein RS, Stewart S, Parfitt AM, Manolagas SC, Jilka RL 2005 Rosiglitazone causes bone loss in mice suppressing osteoblast differentiation and bone formation. Endocrinology 146: 12261235.
  • 41
    Lazarenko O, Rzonca S, Hogue W, Swain F, Suva L, Lecka-Czernik B 2007 Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone. Endocrinology 148: 26692680.
  • 42
    Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL 2002 Divergent effects of selective peroxisome proliferator-activated receptor-gamma2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 143: 23762384.
  • 43
    Lecka-Czernik B, Ackert-Bicknell C, Adamo ML, Marmolejos V, Churchill GA, Shockley K, Reid I, Grey A, Rosen CJ 2007 Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the IGF regulatory system in vitro and in vivo. Endocrinology 148: 903911.
  • 44
    Griffiths M, Remmers E 2001 Genetic analysis of collagen-induced arthritis in rats: A polygenic model for rheumatoid arthritis predicts a common framework of cross-species inflammatory/autoimmune disease loci. Immunol Rev 184: 172183.
  • 45
    de Haan G, Bystrykh L, Weersing E, Dontje B, Geiger H, Ivanova N, Lemischka I, Vellenga E, Van Zant G 2002 A genetic and genomic analysis identifies a cluster of genes associated with hematopoietic cell turnover. Blood 100: 20562062.
  • 46
    Mehrabian M, Allayee H, Stockton J, Lum P, Drake T, Castellani L, Suh M, Armour C, Edwards S, Lamb J, Lusis A, Schadt E 2005 Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nat Genet 37: 12241233.
  • 47
    Berger J, Moller D 2002 The mechanisms of action of PPARs. Annu Rev Med 53: 409435.
  • 48
    Lyons M 2006 Arachidonate 5-lipoxygenase variants in atherosclerosis, obesity, and bone traits. Circ Res 98: e66.
  • 49
    Kuhn H, Anton M, Gerth C, Habenicht A 2003 Amino acid differences in the deduced 5-lipoxygenase sequence of CAST atherosclerosis-resistance mice confer impaired activity when introduced into the human ortholog. Arterioscler Thromb Vasc Biol 23: 10721076.
  • 50
    Foroud T, Ichikawa S, Koller DL, Lai D, Curry L, Edenberg H, Hui SL, Peacock M, Econs MJ 2008 Association studies of ALOX5 and bone mineral density in healthy adults. Osteoporos Int 19: 637643.
  • 51
    Consortium Mot CT 2003 The nature and identification of quantitative trait loci: A community's review. Nat Rev Genet 4: 911916.
  • 52
    Crossno J Jr, Majka S, Grazia T, Gill R, Klemm D 2006 Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest 116: 32203228.
  • 53
    Ogawa S, Urano T, Hosoi T, Miyao M, Hoshino S, Fujita M, Shiraki M, Orimo H, Ouchi Y, Inoue S 1999 Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor gamma expression in osteoblasts. Biochem Biophys Res Commun 260: 122126.
  • 54
    Rhee E-J, Oh K-W, Lee W-Y, Kim S-Y, Oh E-S, Baek K-H, Kang M-I, Kim S-W 2005 The effects of C161[RIGHTWARDS ARROW]T polymorphism in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women. Am J Obstet Gynecol 192: 10871093.
  • 55
    Casado-Diaz A, Cuenca-Acevedo R, Quesada JM, Dorado G 2007 Individual single tube genotyping and DNA pooling by allele-specific PCR to uncover associations of polymorphisms with complex diseases. Clin Chim Acta 376: 155162.
  • 56
    Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL 1999 Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J Cell Biochem 74: 357371.